Scanning, scanning & scanning ...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BABA 84.23 +2.65 (3.25%) < link back
CROX 11.46 +0.16 (1.42%) < link back
IQNT 15.72 +0.56 (3.69%) hod
TUBE 13.13 +0.82 (6.66%) - hod
CECO 6.29 +1.16 (22.61%) < link back
BOBE 46.50 -13.14 (-22.03%) - still watching that one
IQNT 15.62 +0.46 (3.03%) new hod
CECO 6.12 +0.99 (19.30%) < link back
back later ...
IQNT 15.50 +0.34 (2.24%) < link back
HERO, PGN, MHR, BBEP some cheap oil stocks ...
Optionable & shortable ...
http://finviz.com/screener.ashx?v=211&t=HERO,PGN,MHR,BBEP
WBAI 11.54 +0.77 (7.15%) ... sweet < link back
No problem ... good morning !
same here ... back later.
American Eagle Outfitters beats by $0.02, beats on revenue
American Eagle Outfitters (NYSE:AEO): Q4 EPS of $0.36 beats by $0.02.
Revenue of $1.07B (+2.9% Y/Y) beats by $10M.
Shares +7.96% PM.
American Eagle Outfitters beats by $0.02, beats on revenue
American Eagle Outfitters (NYSE:AEO): Q4 EPS of $0.36 beats by $0.02.
Revenue of $1.07B (+2.9% Y/Y) beats by $10M.
Shares +7.96% PM.
ReneSola beats by $0.05, beats on revenue
ReneSola (NYSE:SOL): Q4 EPS of -$0.08 beats by $0.05.
Revenue of $387M (-11.8% Y/Y) beats by $31.92M.
Shares +7.4% PM.
Bristol-Myers inks exclusive option for prostate cancer drug
Bristol-Myers Squibb (NYSE:BMY) acquires an option to license and commercialize Kvistgaard, Denmark-based Bavarian Nordic's Prostvac, Bavarian's investigational prostate-specific antigen (PSA)-targeting cancer immunotherapy currently in Phase 3 development for the treatment of asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC).
Under the terms of the agreement, Bavarian will receive an upfront payment of $60M, an additional $80M if BMY exercises its option based on the results of the Phase 3 trial, incremental payments starting at $50M that could increase to more than $230M if the median overall survival (OS) benefit of Prostvac exceeds the efficacy demonstrated in a Phase 2 study, regulatory milestones of $110M, up to $495M in sales-based milestones and tiered double-digit royalties on net sales. Bavarian will responsible for commercial manufacturing of Prostvac.
A new Phase 2 trial is in the planning stages to assess the combination of Prostvac with BMY's Yervoy (ipilimumab). The firms have also signed an agreement under which they may conduct one or more exploratory combination studies of Prostvac and agents from BMY's immuno-oncology portfolio.
Oasis Petroleum to launch 25M-share public offering
Oasis Petroleum (NYSE:OAS) -4.5% premarket after announcing a public offering of 25M common shares, with an underwriters option to purchase up to another 3.75M shares.
OAS says it intends to use the proceeds to repay outstanding borrowings under its credit facility and for general corporate purposes.
Oasis Petroleum to launch 25M-share public offering
Oasis Petroleum (NYSE:OAS) -4.5% premarket after announcing a public offering of 25M common shares, with an underwriters option to purchase up to another 3.75M shares.
OAS says it intends to use the proceeds to repay outstanding borrowings under its credit facility and for general corporate purposes.
Autohome beats by $0.70, beats on revenue
Autohome (NYSE:ATHM): Q4 EPS of RMB2.37 beats by RMB0.70.
Revenue of RMB739.11M (+91.5% Y/Y) beats by RMB101.51M.
Autohome beats by $0.70, beats on revenue
Autohome (NYSE:ATHM): Q4 EPS of RMB2.37 beats by RMB0.70.
Revenue of RMB739.11M (+91.5% Y/Y) beats by RMB101.51M.
Sociedad Quimica y Minera de Chile beats by $0.02, beats on revenue
Sociedad Quimica y Minera de Chile (NYSE:SQM): Q4 EPS of $0.30 beats by $0.02.
Revenue of $491.4M (-0.2% Y/Y) beats by $61.69M.
Sociedad Quimica y Minera de Chile beats by $0.02, beats on revenue
Sociedad Quimica y Minera de Chile (NYSE:SQM): Q4 EPS of $0.30 beats by $0.02.
Revenue of $491.4M (-0.2% Y/Y) beats by $61.69M.
Country Style Cooking Restaurant Chain reports Q4 results
Country Style Cooking Restaurant Chain (NYSE:CCSC): Q4 EPS of $0.06
Revenue of $58.23M (+28.5% Y/Y)
FairPoint Communications net income of -$43.6M
FairPoint Communications (NASDAQ:FRP): Q4 net income of -$43.6M
Revenue of $217.1M (-7.0% Y/Y) misses by $6.51M.
Xerium EPS of $0.72
Xerium (NYSE:XRM): Q4 EPS of $0.72 may not be comparable to consensus of $0.35.
Revenue of $130.96M (-2.1% Y/Y) misses by $5.07M.
Trina Solar EPS in-line, beats on revenue
Trina Solar (NYSE:TSL): Q4 EPS of $0.13 in-line.
Revenue of $705M (+34.1% Y/Y) beats by $62.12M.
Middleby misses by $0.08, beats on revenue
Middleby (NASDAQ:MIDD): Q4 EPS of $0.91 misses by $0.08.
Revenue of $434.99M (+15.3% Y/Y) beats by $2.49M.
Wayfair beats by $0.10, beats on revenue
Wayfair (NYSE:W): Q4 EPS of -$0.18 beats by $0.10.
Revenue of $408.62M (+38.4% Y/Y) beats by $39.82M.
Wayfair beats by $0.10, beats on revenue
Wayfair (NYSE:W): Q4 EPS of -$0.18 beats by $0.10.
Revenue of $408.62M (+38.4% Y/Y) beats by $39.82M.
Halyard Health beats by $0.82, beats on revenue
Halyard Health (NYSE:HYH): Q4 EPS of $1.59 beats by $0.82.
Revenue of $439.4M (+1.9% Y/Y) beats by $14.3M.
Amedisys beats by $0.01, misses on revenue
Amedisys (NASDAQ:AMED): Q4 EPS of $0.27 beats by $0.01.
Revenue of $300.52M (-1.0% Y/Y) misses by $1.1M.
Installed Building Products misses by $0.04, beats on revenue
Installed Building Products (NYSE:IBP): Q4 EPS of $0.16 misses by $0.04.
Revenue of $145.27M (+21.7% Y/Y) beats by $4.09M.
E.W. Scripps misses by $0.13, misses on revenue
E.W. Scripps (NYSE:SSP): Q4 EPS of $0.27 misses by $0.13.
Revenue of $245.73M (+11.3% Y/Y) misses by $3.03M.